FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Emend

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot #: Z014503, Exp 11/15/2027
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Presence of particulate matter: potential presence of metal particulates in the product.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byNovo Nordisk Production Ireland Limited Athlone, Ireland foreign manufacturer
Brand nameEMEND
Generic nameAPREPITANT
Active ingredient(s)APREPITANT
Distributed by / forMerck Sharpe & Dohme LLC, Rahway, NJ 07065, USA
NDC0006-3066-03
Show the full FDA record
Full product labelMerck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Recalling firmMerck Sharp & Dohme LLC
DistributionNationwide in the USA
Quantity3 - single dose kits
Recall initiated2025-12-12
Report date2025-12-31
Recall completed—
Recall numberD-0241-2026
ClassificationClass II
FDA statusOngoing
Origin on fileWilson NC United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.